We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-13.92%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
-$341M
(-14%)
Cap. Flow
+$97.8M
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
35.92%
Holding
3,540
New
358
Increased
1,256
Reduced
1,110
Closed
245
Avg Time Held Equity + Options
3.1
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.3
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$39.1M |
| 2 |
SPDR Gold Trust
GLD
|
+$26.2M |
| 3 |
Ready Capital
RC
|
+$20.4M |
| 4 |
Corcept Therapeutics
CORT
|
+$16.9M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$16.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$20.7M |
| 2 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$14.1M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$7.79M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$6.54M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.29% |
| 2 | Technology | 12.73% |
| 3 | Financials | 8.79% |
| 4 | Healthcare | 8.35% |
| 5 | Communication Services | 4.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Coupang
CPNG
$25.9B
| $7.01M | 0.32% |
549,577
-9,586
| -2% | -$131K |
2021 Q1
5 quarters
|
|
52
Vanguard High Dividend Yield ETF
VYM
$81B
| $6.9M | 0.32% |
67,865
+22,178
| +49% | +$2.4M |
2016 Q4
22 quarters
|
|
53
Vanguard Short-Term Bond ETF
BSV
$45.4B
| $6.76M | 0.31% |
87,980
+14,959
| +20% | +$1.15M |
2016 Q4
22 quarters
|
|
54
Thermo Fisher Scientific
TMO
$249B
| $6.61M | 0.3% |
12,175
-67
| -0.5% | -$36.9K |
2016 Q4
22 quarters
|
|
55
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $6.55M | 0.3% |
163,357
-49,361
| -23% | -$2.07M |
2016 Q4
22 quarters
|
|
56
Doximity
DOCS
$5.33B
| $6.47M | 0.3% |
185,767
-40
| -0% | -$1.57K |
2021 Q2
4 quarters
|
|
57
Salesforce
CRM
$194B
| $6.44M | 0.3% |
39,013
-487
| -1% | -$86K |
2016 Q4
22 quarters
|
|
58
Eli Lilly
LLY
$1.08T
| $6.29M | 0.29% |
19,384
+206
| +1% | +$61.8K |
2016 Q4
22 quarters
|
|
59
Home Depot
HD
$295B
| $6.25M | 0.29% |
22,770
-1,214
| -5% | -$358K |
2016 Q4
22 quarters
|
|
60
Procter & Gamble
PG
$364B
| $6.14M | 0.28% |
42,731
-212
| -0.5% | -$31.9K |
2016 Q4
22 quarters
|
|
61
iShares MSCI USA Quality Factor ETF
QUAL
$48.7B
| $5.8M | 0.27% |
51,891
-11,969
| -19% | -$1.46M |
2016 Q4
22 quarters
|
|
62
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.55B
| $5.66M | 0.26% |
59,466
+12,764
| +27% | +$1.24M |
2016 Q4
22 quarters
|
|
63
iShares Russell 1000 Value ETF
IWD
$83.1B
| $5.5M | 0.25% |
37,952
-125
| -0.3% | -$19.6K |
2016 Q4
22 quarters
|
|
64
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
| $5.48M | 0.25% |
215,881
-24,793
| -10% | -$648K |
2016 Q4
22 quarters
|
|
65
Uber
UBER
$142B
| $5.4M | 0.25% |
263,761
+23,341
| +10% | +$620K |
2019 Q3
11 quarters
|
|
66
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.87B
| $5.22M | 0.24% |
104,391
-19,320
| -16% | -$968K |
2017 Q3
19 quarters
|
|
67
iShares S&P 500 Value ETF
IVE
$49.5B
| $5.02M | 0.23% |
36,515
+2,706
| +8% | +$399K |
2016 Q4
22 quarters
|
|
68
Palantir
PLTR
$483B
| $4.96M | 0.23% |
547,149
+375
| +0.1% | +$3.71K |
2020 Q4
6 quarters
|
|
69
Payoneer
PAYO
$2.42B
| $4.94M | 0.23% |
1,261,344
-247,378
| -16% | -$1.1M |
2021 Q4
2 quarters
|
|
70
PepsiCo
PEP
$176B
| $4.91M | 0.23% |
29,471
+4,699
| +19% | +$791K |
2016 Q4
22 quarters
|
|
71
Twilio
TWLO
$41.6B
| $4.89M | 0.22% |
58,324
+2,357
| +4% | +$264K |
2018 Q3
15 quarters
|
|
72
Vanguard Real Estate ETF
VNQ
$36.2B
| $4.88M | 0.22% |
53,514
-1,718
| -3% | -$171K |
2016 Q4
22 quarters
|
|
73
Bristol-Myers Squibb
BMY
$121B
| $4.83M | 0.22% |
62,746
+5,336
| +9% | +$406K |
2016 Q4
22 quarters
|
|
74
AbbVie
ABBV
$501B
| $4.73M | 0.22% |
30,860
-420
| -1% | -$64.2K |
2016 Q4
22 quarters
|
|
75
iShares US Medical Devices ETF
IHI
$3.66B
| $4.68M | 0.22% |
92,865
-33,632
| -27% | -$1.83M |
2018 Q4
14 quarters
|
|
Similar funds
Parallel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Parallel Advisors held 3,540 positions worth $2.18B, down 14% from $2.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $97.8M of net new capital in Q2 2022, opening 358 new positions and adding to 1,256 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $20.7M trimmed.
- Parallel Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
- Parallel Advisors added most to Schwab US Dividend Equity ETF in Q2 2022, an estimated $39.1M increase.
- Parallel Advisors's biggest Q2 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $20.7M.
- Parallel Advisors fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $7.79M.
- Parallel Advisors's ten largest holdings make up 36% of its $2.18B portfolio in Q2 2022.
- Parallel Advisors opened 358 new positions and closed 245 in Q2 2022.
- Parallel Advisors's portfolio value fell 14% quarter-over-quarter to $2.18B.
Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.